Gilead Sciences AktieWKN: 885823 / ISIN: US3755581036
Symbol: GILD

62,75EUR
+0,62EUR
+0,99%
12:26:56
73,74USD
+0,40USD
+0,55%
02:10:00
KAUFEN
VERKAUFEN

Gilead Sciences News

23.08.17
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences (MotleyFool)
23.08.17
3 Reasons AbbVie Is a Better Dividend Stock Than Gilead Sciences (FOX Business)
21.08.17
Gilead: Where's the Urgency? (The Wall Street Journal)
21.08.17
Gilead: Where’s the Urgency? (EN, Barrons)
15.08.17
Why Gilead Sciences Might Not Make an Oncology Acquisition (MotleyFool)
10.08.17
Gilead Sciences: Easier Said Than Done (The Wall Street Journal)
10.08.17
Gilead Sciences: Easier Said Than Done (EN, Barrons)
09.08.17
Third Point's Rumored Involvement Boosts Gilead Sciences (The Wall Street Journal)
05.08.17
Is AbbVie About to Deliver a Blow to Gilead Sciences' Guidance? (MotleyFool)
04.08.17
Celgene vs. Gilead Sciences: Who Reported Better Earnings? (MotleyFool)
31.07.17
5 Things Gilead Sciences' Q2 Earnings Numbers Didn't Tell You (MotleyFool)
Heiko Aschoff-Kolumne
Gilead - Gap, Pullback & Go
Ich liebe erstklassige Aktien, die dynamisch auf neue Hochs - am liebsten Allzeithochs - ausbrechen.
27.07.17
Facebook, Gilead Sciences and Discover Financial Services and more (Proactiveinvestors)
27.07.17
Gilead Sciences: The Biggest of Beats? (EN, Barrons)
27.07.17
Gilead shares up 1.9% premarket (MarketWatch)
27.07.17
Facebook, Gilead Sciences and Discover Financial Services - AFTER HOURS (Proactiveinvestors)
27.07.17
Aktionäre von Gilead Sciences erhalten unveränderte Dividende (MyDividends)
27.07.17
BB-Biotech-Beteiligung Gilead: Licht am Ende des Tunnels? (Der Aktionär)
27.07.17
Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense (MotleyFool)
27.07.17
Gilead Sciences, Inc. Boosts Its Full-Year Outlook Thanks to Stronger-Than-Expected Hep C Sales (MotleyFool)
27.07.17
Gilead Sciences, Inc. Boosts Its Full-Year Outlook Thanks to Stronger-Than-Expected Hep C Sales (FOX Business)
26.07.17
Gilead boosts outlook higher after healthier-than-expected results (Financial Times)
26.07.17
Gilead Sciences shares rise after quarterly results top Street view (Market Watch)
26.07.17
Gilead shares rise 2% after hours following earnings beat (MarketWatch)
26.07.17
Gilead adjusted Q2 EPS $2.56 vs Street view of $2.14 (MarketWatch)
26.07.17
Gilead Q2 revenue $7.14 bln vs $7.78 bln year ago (MarketWatch)
26.07.17
Gilead Q2 EPS $2.33 vs $2.58 year ago (MarketWatch)
26.07.17
Gilead Sciences, Verizon Communications, And MGM Resorts Report Q2 Results This Week (EN, Benzinga earnings)
24.07.17
3 Things You Can Expect in Gilead Sciences' Q2 Update (MotleyFool)
24.07.17
Gilead Sciences: There's Always Safety (The Wall Street Journal)
24.07.17
Gilead Sciences: There’s Always Safety (EN, Barrons)
24.07.17
Gilead Sciences says late-stage results for HIV drug combination are similar to standard of care (Market Watch)
24.07.17
Gilead stock surges 0.7% on late-stage HIV trial results (MarketWatch)
24.07.17
Gilead Sciences says late-stage results for HIV drug combination are similar to standard of care (MarketWatch)
22.07.17
Better Buy: Celgene Corporation vs. Gilead Sciences, Inc. (MotleyFool)
21.07.17
Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter? (EN, Barrons)
21.07.17
Will Gilead Beat 2Q Earnings? Perhaps…But Does It Matter? (The Wall Street Journal)
21.07.17
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences (MotleyFool)
21.07.17
Better Buy: Valeant Pharmaceuticals International, Inc. vs. Gilead Sciences (FOX Business)
19.07.17
Gilead Sciences: Not a Game Changer (The Wall Street Journal)
Seite: 123456789...25

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln

Willkommen bei finanzen.net Brokerage

Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus finanzen.net!

Weitere Informationen finden Sie hier.

Jetzt informieren und Depot eröffnen


Sie haben bereits ein Depot? Dann verknüpfen Sie es jetzt mit Ihrem finanzen.net-Account!

Jetzt verknüpfen

Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Daimler AG710000
Volkswagen (VW) AG Vz.766403
Apple Inc.865985
CommerzbankCBK100
TeslaA1CX3T
EVOTEC AG566480
K+S AGKSAG88
E.ON SEENAG99
BMW AG519000
BVB (Borussia Dortmund)549309
Amazon906866
AlibabaA117ME
Baumot Group AGA2DAM1
ProSiebenSat.1 Media SEPSM777